Scilex Holding Company (SCLX)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $8.79M
Last updated: Nov 17, 2026 at 4:22 PM ET
Scilex Holding Company (SCLX) Statistics
Scilex Holding Company (SCLX) has a market cap of $8.79M and an enterprise value of $89.03M. It kept -1833.55% of revenue as net income over the last 12 months. Its net debt of $80.24M equals 912.50% of its market cap.
Total Valuation
Enterprise value is 912.50% above the market cap, as debt exceeds cash.
| Market Cap | $8.79M |
|---|---|
| Enterprise Value | $89.03M |
| Latest price (Nov 17, 2026) | $0.64 |
Key Dates
The next earnings report is expected on Apr 8, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Apr 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Aug 14, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 94.17% over 52 weeks and trades 80.12% below its 50-day average.
| Beta (1Y) | 1.41 |
|---|---|
| 52-Week Change | -94.17% |
| 1-Month Change | -75.02% |
| 3-Month Change | -88.64% |
| 6-Month Change | -82.76% |
| 5-Year Change | -99.15% |
| Total Return (1Y) | -94.17% |
| Total Return (3Y CAGR) | -69.80% |
| Total Return (5Y CAGR) | -68.89% |
| Max Drawdown (1Y) | -95.42% |
| Max Drawdown (3Y) | -98.78% |
| Sharpe Ratio (1Y) | -2.39 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $3.22 |
| 200-Day Average | $5.03 |
| 52-Week Range | $1.24 to $16.81 |
| RSI (14 Days) | 7.8 |
| Average Volume (20 Days) | 73.09K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.07x current liabilities.
| Current Ratio | 0.07x |
|---|---|
| Quick Ratio | 0.06x |
| Interest Coverage | -17.57x |
Returns and Efficiency
Return on invested capital is 143.52% over the last 12 months, against a 5-year average of 131.84%.
| Return on Assets (ROA) | -228.56% |
|---|---|
| Return on Invested Capital (ROIC) | 143.52% |
| ROA (5Y Average) | -86.83% |
| ROIC (5Y Average) | 131.84% |
| Asset Turnover | 0.19x |
| Inventory Turnover | 3.23x |
| Receivables Turnover | 1.14x |
| Cash Conversion Cycle | -2455 days |
Scores
SCLX has an Altman Z-Score of -13.46, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -13.46 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $31.61M over the last 12 months is down 28.55% from the 12 months before.
| Revenue | $31.61M |
|---|---|
| Revenue Growth (YoY) | -28.55% |
| Gross Profit | $17.54M |
| Operating Income | -$359.19M |
| Pretax Income | -$464.55M |
| Net Income | -$579.55M |
| EBIT | -$413.33M |
| Reported EPS (TTM) | -$40.28 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
| Cash and Equivalents | $566.00K |
|---|---|
| Total Debt | $80.81M |
| Net Debt | $80.24M |
| Net Debt Per Share | $11.64 |
| Working Capital | -$476.01M |
| Shareholder Equity | -$308.32M |
| Tangible Book Value | -$379.41M |
| Total Assets | $253.56M |
| Total Liabilities | $564.05M |
Balance sheet as of Jun 30, 2026.
Cash Flow
| Operating Cash Flow | -$17.09M |
|---|---|
| FCF Per Share | -$2.92 |
| Depreciation and Amortization | $10.74M |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -1136.40%.
| Gross Margin | 55.50% |
|---|---|
| Operating Margin | -1136.40% |
| Pretax Margin | -1469.71% |
| Net Margin | -1833.55% |
| EBIT Margin | -1307.68% |
| Gross Margin (5Y Average) | 72.39% |
Growth
Revenue fell 7.35% a year over 3 years.
| Revenue Growth (3Y CAGR) | -7.35% |
|---|---|
| Revenue Growth (5Y CAGR) | +5.13% |
Stock Splits
The last forward split was on Jun 16, 2026.
| Last Split Date | Jun 16, 2026 |
|---|---|
| Split Type | Forward split |
Peer Position
Against 3 similar companies, SCLX has the lowest P/S and the highest ROIC.
P/S RatioPeer median 3.0x
ROICPeer median -56.16%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -100.00%
| P/S Ratio | 0.1x vs 3.0x median |
|---|---|
| ROIC | 143.52% vs -56.16% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -28.55% vs -100.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 149.92% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +149.92% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SCLX
What is SCLX's market cap?
Scilex Holding Company has a market cap of $8.79M. Its enterprise value, which adds debt and subtracts cash, is $89.03M.
How many shares of SCLX are outstanding?
Scilex Holding Company has 6.89M shares outstanding. The count is down 40.56% from a year earlier.
Does SCLX pay a dividend?
No. Scilex Holding Company does not pay a dividend.
How much debt does SCLX have?
Scilex Holding Company has $80.81M of total debt and $566.00K of cash and equivalents, a net debt position of $80.24M.
SCLX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors